A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review

John R. De Almeida, James K. Byrd, Rebecca Wu, Chaz L. Stucken, Uma Duvvuri, David P. Goldstein, Brett A. Miles, Marita S. Teng, Vishal Gupta, Eric M. Genden

Research output: Contribution to journalReview article

94 Citations (Scopus)

Abstract

Objectives/Hypothesis To demonstrate the comparative effectiveness of transoral robotic surgery (TORS) to intensity modulated radiotherapy (IMRT) for early T-stage oropharyngeal cancer. Data Sources The search included MEDLINE, EMBASE, CENTRAL, PsychInfo, CINAHL, and bibliographies of relevant studies through September 2012. Methods Studies included patients treated for early T-stage oropharynx cancer with TORS or IMRT. Study retrieval and data extraction were conducted in duplicate and resolved by consensus. Treatment- specific details, as well as recurrence, survival, and adverse events, were collected. Methodologic quality for each study was appraised. Results Twenty case series, including eight IMRT studies (1,287 patients) and 12 TORS studies (772 patients), were included. Patients receiving definitive IMRT also received chemotherapy (43%) or neck dissections for persistent disease (30%), whereas patients receiving TORS required adjuvant radiotherapy (26%) or chemoradiotherapy (41%). Two-year overall survival estimates ranged from 84% to 96% for IMRT and from 82% to 94% for TORS. Adverse events for IMRT included esophageal stenosis (4.8%), osteoradionecrosis (2.6%), and gastrostomy tubes (43%) - and adverse events for TORS included hemorrhage (2.4%), fistula (2.5%), and gastrostomy tubes at the time of surgery (1.4%) or during adjuvant treatment (30%). Tracheostomy tubes were needed in 12% of patients at the time of surgery, but most were decannulated prior to discharge. Conclusion This review suggests that survival estimates are similar between the two modalities and that the differences lie in adverse events.

Original languageEnglish (US)
Pages (from-to)2096-2102
Number of pages7
JournalLaryngoscope
Volume124
Issue number9
DOIs
StatePublished - Sep 2014

Fingerprint

Oropharyngeal Neoplasms
Robotics
Intensity-Modulated Radiotherapy
Radiotherapy
Gastrostomy
Information Storage and Retrieval
Survival
Adjuvant Chemoradiotherapy
Osteoradionecrosis
Esophageal Stenosis
Adjuvant Radiotherapy
Neck Dissection
Tracheostomy
Bibliography
MEDLINE
Fistula
Hemorrhage
Recurrence
Drug Therapy

Keywords

  • IMRT
  • TORS
  • adverse events
  • oropharynx cancer
  • outcomes
  • survival

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

De Almeida, J. R., Byrd, J. K., Wu, R., Stucken, C. L., Duvvuri, U., Goldstein, D. P., ... Genden, E. M. (2014). A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review. Laryngoscope, 124(9), 2096-2102. https://doi.org/10.1002/lary.24712

A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer : A systematic review. / De Almeida, John R.; Byrd, James K.; Wu, Rebecca; Stucken, Chaz L.; Duvvuri, Uma; Goldstein, David P.; Miles, Brett A.; Teng, Marita S.; Gupta, Vishal; Genden, Eric M.

In: Laryngoscope, Vol. 124, No. 9, 09.2014, p. 2096-2102.

Research output: Contribution to journalReview article

De Almeida, JR, Byrd, JK, Wu, R, Stucken, CL, Duvvuri, U, Goldstein, DP, Miles, BA, Teng, MS, Gupta, V & Genden, EM 2014, 'A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review', Laryngoscope, vol. 124, no. 9, pp. 2096-2102. https://doi.org/10.1002/lary.24712
De Almeida, John R. ; Byrd, James K. ; Wu, Rebecca ; Stucken, Chaz L. ; Duvvuri, Uma ; Goldstein, David P. ; Miles, Brett A. ; Teng, Marita S. ; Gupta, Vishal ; Genden, Eric M. / A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer : A systematic review. In: Laryngoscope. 2014 ; Vol. 124, No. 9. pp. 2096-2102.
@article{3f000b4794934f1d9767da14794377d5,
title = "A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review",
abstract = "Objectives/Hypothesis To demonstrate the comparative effectiveness of transoral robotic surgery (TORS) to intensity modulated radiotherapy (IMRT) for early T-stage oropharyngeal cancer. Data Sources The search included MEDLINE, EMBASE, CENTRAL, PsychInfo, CINAHL, and bibliographies of relevant studies through September 2012. Methods Studies included patients treated for early T-stage oropharynx cancer with TORS or IMRT. Study retrieval and data extraction were conducted in duplicate and resolved by consensus. Treatment- specific details, as well as recurrence, survival, and adverse events, were collected. Methodologic quality for each study was appraised. Results Twenty case series, including eight IMRT studies (1,287 patients) and 12 TORS studies (772 patients), were included. Patients receiving definitive IMRT also received chemotherapy (43{\%}) or neck dissections for persistent disease (30{\%}), whereas patients receiving TORS required adjuvant radiotherapy (26{\%}) or chemoradiotherapy (41{\%}). Two-year overall survival estimates ranged from 84{\%} to 96{\%} for IMRT and from 82{\%} to 94{\%} for TORS. Adverse events for IMRT included esophageal stenosis (4.8{\%}), osteoradionecrosis (2.6{\%}), and gastrostomy tubes (43{\%}) - and adverse events for TORS included hemorrhage (2.4{\%}), fistula (2.5{\%}), and gastrostomy tubes at the time of surgery (1.4{\%}) or during adjuvant treatment (30{\%}). Tracheostomy tubes were needed in 12{\%} of patients at the time of surgery, but most were decannulated prior to discharge. Conclusion This review suggests that survival estimates are similar between the two modalities and that the differences lie in adverse events.",
keywords = "IMRT, TORS, adverse events, oropharynx cancer, outcomes, survival",
author = "{De Almeida}, {John R.} and Byrd, {James K.} and Rebecca Wu and Stucken, {Chaz L.} and Uma Duvvuri and Goldstein, {David P.} and Miles, {Brett A.} and Teng, {Marita S.} and Vishal Gupta and Genden, {Eric M.}",
year = "2014",
month = "9",
doi = "10.1002/lary.24712",
language = "English (US)",
volume = "124",
pages = "2096--2102",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer

T2 - A systematic review

AU - De Almeida, John R.

AU - Byrd, James K.

AU - Wu, Rebecca

AU - Stucken, Chaz L.

AU - Duvvuri, Uma

AU - Goldstein, David P.

AU - Miles, Brett A.

AU - Teng, Marita S.

AU - Gupta, Vishal

AU - Genden, Eric M.

PY - 2014/9

Y1 - 2014/9

N2 - Objectives/Hypothesis To demonstrate the comparative effectiveness of transoral robotic surgery (TORS) to intensity modulated radiotherapy (IMRT) for early T-stage oropharyngeal cancer. Data Sources The search included MEDLINE, EMBASE, CENTRAL, PsychInfo, CINAHL, and bibliographies of relevant studies through September 2012. Methods Studies included patients treated for early T-stage oropharynx cancer with TORS or IMRT. Study retrieval and data extraction were conducted in duplicate and resolved by consensus. Treatment- specific details, as well as recurrence, survival, and adverse events, were collected. Methodologic quality for each study was appraised. Results Twenty case series, including eight IMRT studies (1,287 patients) and 12 TORS studies (772 patients), were included. Patients receiving definitive IMRT also received chemotherapy (43%) or neck dissections for persistent disease (30%), whereas patients receiving TORS required adjuvant radiotherapy (26%) or chemoradiotherapy (41%). Two-year overall survival estimates ranged from 84% to 96% for IMRT and from 82% to 94% for TORS. Adverse events for IMRT included esophageal stenosis (4.8%), osteoradionecrosis (2.6%), and gastrostomy tubes (43%) - and adverse events for TORS included hemorrhage (2.4%), fistula (2.5%), and gastrostomy tubes at the time of surgery (1.4%) or during adjuvant treatment (30%). Tracheostomy tubes were needed in 12% of patients at the time of surgery, but most were decannulated prior to discharge. Conclusion This review suggests that survival estimates are similar between the two modalities and that the differences lie in adverse events.

AB - Objectives/Hypothesis To demonstrate the comparative effectiveness of transoral robotic surgery (TORS) to intensity modulated radiotherapy (IMRT) for early T-stage oropharyngeal cancer. Data Sources The search included MEDLINE, EMBASE, CENTRAL, PsychInfo, CINAHL, and bibliographies of relevant studies through September 2012. Methods Studies included patients treated for early T-stage oropharynx cancer with TORS or IMRT. Study retrieval and data extraction were conducted in duplicate and resolved by consensus. Treatment- specific details, as well as recurrence, survival, and adverse events, were collected. Methodologic quality for each study was appraised. Results Twenty case series, including eight IMRT studies (1,287 patients) and 12 TORS studies (772 patients), were included. Patients receiving definitive IMRT also received chemotherapy (43%) or neck dissections for persistent disease (30%), whereas patients receiving TORS required adjuvant radiotherapy (26%) or chemoradiotherapy (41%). Two-year overall survival estimates ranged from 84% to 96% for IMRT and from 82% to 94% for TORS. Adverse events for IMRT included esophageal stenosis (4.8%), osteoradionecrosis (2.6%), and gastrostomy tubes (43%) - and adverse events for TORS included hemorrhage (2.4%), fistula (2.5%), and gastrostomy tubes at the time of surgery (1.4%) or during adjuvant treatment (30%). Tracheostomy tubes were needed in 12% of patients at the time of surgery, but most were decannulated prior to discharge. Conclusion This review suggests that survival estimates are similar between the two modalities and that the differences lie in adverse events.

KW - IMRT

KW - TORS

KW - adverse events

KW - oropharynx cancer

KW - outcomes

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84906656639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906656639&partnerID=8YFLogxK

U2 - 10.1002/lary.24712

DO - 10.1002/lary.24712

M3 - Review article

C2 - 24729006

AN - SCOPUS:84906656639

VL - 124

SP - 2096

EP - 2102

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 9

ER -